CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 89 enrolled
Drug / intervention
Levalbuterol +1 moredrug
Likely dose
Levalbuterol 0.625 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01151579
NCT01151579Phase 4Completed
CompareCT.gov

Prospective Trial of Effect of Nebulized Bronchodilators on Heart Rate and Arrhythmias in Critically Ill Adult Patients

Fahim Khorfan, MD·interventional·Posted Jun 28, 2010·Updated Oct 23, 2015

In Brief

A Phase 4 clinical trial evaluating Levalbuterol and Albuterol for COPD and 2 related conditions. Completed, enrolled 89 participants across 1 site.

Detailed Summary

The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOPD, Sepsis, Shock
CountriesUnited States
CollaboratorsAscension Health

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2010
Enrollment StartDec 1, 2008
Primary CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.0 years ago

Interventions

Levalbuteroldrug

inhaled Levalbuterol 0.625 mg inhaled Levalbuterol 2.5 mg

Albuteroldrug

Nebulized albuterol 2.5mg